Attorney Wendy R. Fleishman of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that four young men prescribed the antipsychotic medication Risperdal recently filed separate personal injury lawsuits alleging that Risperdal is a defective and dangerous prescription drug. The complaints were brought against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the manufacturer of Risperdal, in state court in Pennsylvania, where Janssen Pharmaceuticals is located.
The plaintiffs, from the states of Connecticut, Florida, Maryland, and Ohio, were prescribed Risperdal as adolescents. While taking the recommended dosage of Risperdal, each male child plaintiff developed the growth of abnormal breast tissue. In medical terms, this condition is called gynecomastia. This is not merely fatty deposits in the pectoral muscles of the chest, but real breasts that look like women’s breasts.
“The bodies of these young men have been permanently mutated by Risperdal. In a young man who is already isolated by his challenges caused by mental issues, the growth of women’s breasts on his body in adolescent and teenage years is absolutely devastating,” stated Fleishman. “As alleged in the complaint, Janssen knew Risperdal stimulated male breast development and failed to adequately warn physicians, parents, and the adolescents prescribed Risperdal of this side effect. So when the moms and dads gave their consent to add this prescription for their sons, they knew nothing about the potential horrible harm it could cause.”
Federal law requires that prescription drug manufacturers fully and accurately disclose information in relation to adverse effects of their medications on the package insert and other labeling, and to include adequate warnings concerning these risks in promotional materials for the medications.
“The master complaint in the Risperdal litigation charges that the defendants manipulated clinical trials to produce results favorable to Risperdal and failed to file accurate and timely reports of adverse events in patients prescribed Risperdal,” stated Lieff Cabraser attorney Jeremy J. Troxel, who also represents Risperdal patients. “The complaint further alleges that defendants made false and misleading claims, regarding the risks of Risperdal and failed to issue adequate warnings concerning the dangers of ingesting Risperdal.”
Contact Lieff Cabraser
If you or a family member has developed gynecomastia after being prescribed Risperdal, you may be eligible to file a claim.
Please visit our Risperdal injuries page to contact Lieff Cabraser for a free and prompt evaluation of your case, with no obligation on your part.
About Lieff Cabraser
Recognized as “one of the nation’s premier plaintiffs’ firms” by The American Lawyer, Lieff Cabraser Heimann & Bernstein, LLP is a sixty-plus attorney law firm with offices in San Francisco, New York, and Nashville. Our firm has successfully represented thousands of patients across America in individual lawsuits due to the injuries they suffered from dangerous prescription drugs with undisclosed side effects.
U.S. News and Best Lawyers have named Lieff Cabraser as their 2015 “Law Firm of the Year” for representing plaintiffs in class actions and mass torts. Law360 has recognized Lieff Cabraser with its practice group of the year award for the successes we have achieved for our clients in personal injury and mass torts cases.
Trademark and Attorney Advertising Notice
Risperdal is a registered trademark of Johnson & Johnson and its subsidiary Janssen Pharmaceuticals. The use of this trademark is solely for product identification and informational purposes. Lieff Cabraser has no affiliation with Johnson & Johnson or Janssen Pharmaceuticals.
This press release may be considered attorney advertising in certain jurisdictions. Any testimonial or endorsement does not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. Every legal matter is different. The outcome of your claim or case depends upon many factors, including the specific facts of your claim or case. Prior results do not guarantee a similar outcome.
Lieff Cabraser Heimann & Bernstein, LLP